Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2002
03/13/2002EP0802910B1 Estrogen agonists/antagonists
03/13/2002EP0782445B1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
03/13/2002EP0764025B1 Method and medicine for alleviating jet lag
03/13/2002EP0652757B1 Sugar-free dry mix cellulose ether compositions as bulk laxatives
03/13/2002EP0596897B1 Hydroisoquinoline derivatives
03/13/2002CN1340103A Complex-forming proteins
03/13/2002CN1340102A Polypeptide variants with raised heparin-binding capacity
03/13/2002CN1340098A Astrocytes, their preparation and use thereof
03/13/2002CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4
03/13/2002CN1340056A Steroides sulfatase inhibitors and methods for making and using same
03/13/2002CN1340055A Shortened-chain polynucleotide and process for the preparation thereof
03/13/2002CN1340054A 2-amino-6-anilino-purines and their use as medicaments
03/13/2002CN1340053A Epothilon derivatives, method for the production and the use as pharmaceuticals
03/13/2002CN1340052A Process for the production of tert-butyl (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin 5-yl] (4R,6S)-2,2-dimethyl [1,3] dioxan-4-yl) acetate
03/13/2002CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents
03/13/2002CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists
03/13/2002CN1340046A β-丙氨酸衍生物 β- alanine derivatives
03/13/2002CN1340045A 5-HTIF agonists
03/13/2002CN1340044A Nervinolin derivatives
03/13/2002CN1340043A Phenylalaninol derivatives
03/13/2002CN1339969A Liposone composition and method for administration of a radiosensitizer
03/13/2002CN1339967A Composition for treatinb obesity and aesthetic treating method
03/13/2002CN1339966A Medicament for treating hypertension
03/13/2002CN1339965A Combinations of formoterol and fluticasone propionate for asthma
03/13/2002CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions
03/13/2002CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances
03/13/2002CN1339944A Organoprotective solutions
03/13/2002CN1339442A Schizophyllary tetrasaccharide cluster compound and its preparing method and use
03/13/2002CN1339436A Method for preparing xitaipulan
03/13/2002CN1339435A Method for preparing xitaipulan
03/13/2002CN1339312A Wound plaster of yannan Baiyao and its preparing method
03/13/2002CN1339310A Shaddock-lozenge tablet and its producing method
03/13/2002CN1339306A Gastric ulcer ointment
03/13/2002CN1339301A New lactic acid fungus preparation having biological purifying activity
03/13/2002CN1339299A Method for preparing medicine for urogenital system
03/13/2002CN1339298A Compound traditional medicine with piperine for increasing biological utilization of paeoniflorin and its preparing method
03/13/2002CN1339297A New medicine release system-liposolubility medicinal preparation
03/13/2002CN1080720C 噻唑衍生物 Thiazole derivatives
03/13/2002CN1080718C Vitamin D amine and amine derivatives
03/13/2002CN1080574C Yuchuang ointment for treating sore
03/13/2002CN1080566C Mixtures derived from eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicines
03/13/2002CN1080565C External-use capsule for curing woman diseases
03/13/2002CN1080562C Use of prostance derivatives and the combination with antibiotics in the treatment of bacterial infections
03/13/2002CN1080561C Anti-inflammatory agent for external use
03/13/2002CN1080560C Oral medicinal liquor for abstaining from taking drug and production technology thereof
03/12/2002US6355813 Intermediates useful in preparing these compounds
03/12/2002US6355811 Polyoxypropylenepolyethylene vitamin E and preparation thereof
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355798 Ligands for gamma-aminobutyric acid receptors; anticonvulsants, anxiolytic agents
03/12/2002US6355695 Antihistamines; asthma therapy
03/12/2002US6355692 Administering polyhydroxylated stilbene
03/12/2002US6355691 Anticancer agents; immunology response; applying to catheters
03/12/2002US6355690 Remedy for CAG repeat expansion diseases
03/12/2002US6355689 Antiinflammatory agents
03/12/2002US6355688 Administering toremifene citrate
03/12/2002US6355686 Cosmetic compositions containing substituted amine derivatives
03/12/2002US6355685 Using n,n-dimethyl-1-((1-(4-chlorophenyl)cyclobutyl)-3-methylbutylam ine hydrochloride
03/12/2002US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/12/2002US6355683 Fc receptor modulators and uses thereof
03/12/2002US6355682 Treatment of acute renal failure by administration of N-acetylcysteine
03/12/2002US6355681 Glycine substitutes and precursors for treating a psychosis
03/12/2002US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
03/12/2002US6355677 Adrenoleukodystrophy treatments and drug screening
03/12/2002US6355676 Skin disorders; antiarthritic agents
03/12/2002US6355673 Substituted diaminocarboxylic acids
03/12/2002US6355670 Skin disorders
03/12/2002US6355669 Retinoic acid agonists as preventive and therapeutic agents for nephritis
03/12/2002US6355668 Bicycloloactam compounds, use thereof and intermediates for preparing thereof
03/12/2002US6355666 Protected forms of pharmacologically active agents and uses therefor
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355661 Methods for treatment of sickle cell anemia
03/12/2002US6355660 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/12/2002US6355658 Coumarin derivatives, methods of preparation and application as medicines
03/12/2002US6355657 Loperamide hydrochloride in propylene carbonate and ethanol
03/12/2002US6355656 Phenidate drug formulations having diminished abuse potential
03/12/2002US6355655 Treating a cognitive disorder, a neuro-degenerative disorder; age-related dementia; age-induced memory impairment; a movement disorder, attention deficit disorder; attention deficit hyperactivity disorder; psychosis; cognitive deficits
03/12/2002US6355654 Salts of quinoline derivatives as NK3 antagonists
03/12/2002US6355653 Amino-triazolopyridine derivatives
03/12/2002US6355650 Leukocyte antiadhesion agents
03/12/2002US6355649 4-azasteroid enzyme inhibitors
03/12/2002US6355648 Thio-oxindole derivatives
03/12/2002US6355647 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use
03/12/2002US6355646 Immunology treatment of inflammatory conditions and immune disorders septic shock
03/12/2002US6355645 4-(3'-bromobenzoyl)-6,7-dimethoxyquinazoline; for lowering blood cholesterol, including reducing total cholesterol and ldl-cholesterol levels
03/12/2002US6355643 Enzyme inhibitors, ras genes and proteins
03/12/2002US6355640 Pyrazolopyridine adenosine antagonists
03/12/2002US6355639 Reverse prenyl compounds as immunosuppressants
03/12/2002US6355638 Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
03/12/2002US6355636 Enzyme inhibitors
03/12/2002US6355632 Naphthyl compounds, intermediates, compositions, and methods
03/12/2002US6355629 Intracellular transporting adjuvant
03/12/2002US6355628 Combination therapy using pentafluorobenzenesulfonamides
03/12/2002US6355627 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same
03/12/2002US6355626 Antithrombin agents in treatment of asthma
03/12/2002US6355623 Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
03/12/2002US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell
03/12/2002US6355620 C-2 modified erythromycin derivatives
03/12/2002US6355615 Cyclic polyamideester copolymers
03/12/2002US6355614 Drugs of cyclic boroproline with carriers